ATMA CENA training is organized into three specialized pathways—Integrative, Clinical, and Prescriber—each designed for your professional role.
All pathways begin with Psychedelic-Assisted Therapy Foundations and build toward supervised clinical experience within our collaborative care model.
Explore the courses below to find your pathway.
Register for our next Foundations cohort!
The Clinical Pathway is for clinicians preparing to deliver regulated psychedelic-assisted therapy — with a supported path into practice through the ATMA CENA CoCare Model
Next Cohort Registration Deadline: March 2nd, 2026
The Clinical Pathway includes two courses: Psychedelic-Assisted Therapy Foundations & Applied Clinical Practice in Psychedelic Therapy, and is available at a 10% bundle discount.
The Prescriber Pathway is for psychiatrists, physicians, nurse practitioners and other prescribers who are either integrating innovative mental health therapy into their clinical scope or seeking to better understand psychedelic-assisted therapy for referral and collaborative care.
Next Cohort Registration Deadline: March 2nd, 2026
The Prescriber Pathway includes two courses: Psychedelic-Assisted Therapy Foundations & Prescribing & Oversight in Psychedelic Therapy, and is available at a 10% bundle discount.
The Integrative Pathway is for integrated health and wellness professionals seeking foundational knowledge to better support clients or collaborate in this space.
Next Cohort Registration Deadline: March 2nd, 2026
The Integrative Pathway includes two courses: Psychedelic-Assisted Therapy Foundations & Advanced Safety & Support Practices in Psychedelic Therapy, and is available at a 10% bundle discount.
This course is part of the Clinical Pathway
A clinician-designed pathway building confidence in psychedelic-assisted therapy, including ketamine-assisted therapy, with ethical grounding and a supported route to real-world application through CoCare. This program is best suited for regulated mental healthcare professionals and is part two of our Clinical Pathway.
This course is part of the Prescriber Pathway
Created for physicians and licensed prescribers as part two of our Prescriber Pathway, this course is meant to equip licensed prescribers with the advanced medical knowledge, clinical protocols, and regulatory literacy required to safely evaluate, prescribe, and oversee psychedelic-assisted therapy (PAT) within licensed and interdisciplinary settings.
This course is part of the Integrative Pathway
Designed as part two of our Integrative Pathway, this course helps practitioners build an informed and ethical understanding of psychedelic-assisted therapy. It prepares participants to thoughtfully support clients navigating psychedelic experiences in other settings, with clarity around professional boundaries, scope, and best practices.
This course is a required prerequisite for all of our Advanced Pathways: the Integrative Pathway, the Clinical Pathway, and the Prescriber Pathway.
This course is the foundation for all of our Advanced Pathways. It explores the history, science, and therapeutic potential of psychedelics. This training sets the stage for deeper clinical application. It is the starting point for all ATMA CENA training and a prerequisite for further certification.
This course is only available to ATMA CENA alumni who have already completed our Introduction to Psychedelic-Assisted Therapy AND Advanced Psychedelic-Assisted Therapy Certification Program.
This course is not part of our advanced pathways and will be discontinued in the spring of 2026. All alumni will retain lifetime access.
This course provides essential knowledge and practical skills for supporting clients through ketamine-assisted therapy using a structured clinical protocol. Emphasis is placed on safety, integration, and team-based care delivery.
Notice: This course will no longer be offered after March 31, 2026.
The Supervised Learning Lab is an optional addition for students who have completed the Clinical Pathway.
The Supervised Learning Lab is a small group, therapist led learning experience designed to support clinicians as they deepen their understanding of psychedelic assisted therapy through real case informed discussion and applied practical knowledge. Delivered over four weekly sessions, the Lab provides a structured, supportive space to translate theory into practice, exploring readiness, therapeutic processes, and integration through a clinical lens.
The KAT Immersive Experience is an optional part of any of our Advanced Training Pathways.
The KAT Immersive Experience is in-person clinical experience designed for practitioners who want to deepen their understanding of psychedelic-assisted therapy by moving through the process from the client perspective. When joining a group cohort, clinicians will experience the full arc of KAT care, from intake and preparation through dosing sessions and integration, while developing practical insight into intention setting, holding space, and integration approaches.
